Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:41 pm Sale |
2024-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Madison Avenue International LP | 2,852,352 4.000% |
-796,157 (-21.82%) |
Filing History |
| 2024-11-14 6:01 pm Sale |
2024-09-30 | 13G | Ovid Therapeutics Inc. OVID |
EcoR1 Capital LLC | 0 0.000% |
-6,117,400 (Position Closed) |
Filing History |
| 2024-11-14 4:39 pm Sale |
2024-09-30 | 13G | Ovid Therapeutics Inc. OVID |
BIOTECHNOLOGY VALUE FUND L P | 3,853,818 5.400% |
-2,997,233 (-43.75%) |
Filing History |
| 2024-02-14 4:15 pm Sale |
2023-12-31 | 13G | Ovid Therapeutics Inc. OVID |
LEVIN JEREMY M | 6,942,181 9.400% |
-338,940 (-4.66%) |
Filing History |
| 2024-02-14 11:10 am Purchase |
2023-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Madison Avenue International LP | 3,648,509 5.200% |
39,455 (+1.09%) |
Filing History |
| 2024-02-12 06:06 am Sale |
2023-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Rubric Capital Management LP | 5,315,969 7.520% |
-1,512,096 (-22.15%) |
Filing History |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Ovid Therapeutics Inc. OVID |
BLACKROCK INC BLK |
4,319,918 6.100% |
3,117,188 (+259.18%) |
Filing History |
| 2023-07-31 5:21 pm Purchase |
2023-07-20 | 13G | Ovid Therapeutics Inc. OVID |
Madison Avenue International LP | 3,609,054 5.100% |
3,609,054 (New Position) |
Filing History |
| 2023-02-14 4:01 pm Purchase |
2022-12-31 | 13G | Ovid Therapeutics Inc. OVID |
LEVIN JEREMY M | 7,281,121 10.000% |
726,351 (+11.08%) |
Filing History |
| 2023-02-13 6:22 pm Purchase |
2022-12-31 | 13G | Ovid Therapeutics Inc. OVID |
BIOTECHNOLOGY VALUE FUND L P | 6,851,051 9.700% |
220,000 (+3.32%) |
Filing History |
| 2023-02-13 10:28 am Sale |
2022-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Stonepine Capital Management, LLC | 0 0.000% |
-4,006,185 (Position Closed) |
Filing History |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Rubric Capital Management LP | 6,828,065 9.690% |
6,828,065 (New Position) |
Filing History |
| 2023-02-10 2:28 pm Purchase |
2022-12-31 | 13G | Ovid Therapeutics Inc. OVID |
EcoR1 Capital LLC | 6,117,400 8.700% |
35,200 (+0.58%) |
Filing History |
| 2023-02-09 11:30 am Sale |
2022-12-30 | 13G | Ovid Therapeutics Inc. OVID |
The Vanguard Group | 2,581,736 3.660% |
-860,882 (-25.01%) |
Filing History |
| 2023-02-03 11:50 am Unchanged |
2022-06-21 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
TAKEDA PHARMACEUTICAL CO LTD | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-03 11:48 am Purchase |
2022-07-01 | 13G | Ovid Therapeutics Inc. OVID |
TAKEDA PHARMACEUTICAL CO LTD | 8,781,996 12.200% |
1,250,000 (+16.60%) |
Filing History |
| 2022-02-14 5:29 pm Sale |
2021-12-31 | 13G | Ovid Therapeutics Inc. OVID |
During Matthew | 3,103,932 4.500% |
-916,862 (-22.80%) |
Filing History |
| 2022-02-14 4:31 pm Purchase |
2021-12-31 | 13G | Ovid Therapeutics Inc. OVID |
LEVIN JEREMY M | 6,554,770 9.400% |
462,500 (+7.59%) |
Filing History |
| 2022-02-14 3:21 pm Purchase |
2021-12-31 | 13G | Ovid Therapeutics Inc. OVID |
EcoR1 Capital LLC | 6,082,200 8.900% |
6,082,200 (New Position) |
Filing History |
| 2022-02-11 5:47 pm Purchase |
2021-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Stonepine Capital Management, LLC | 4,006,185 5.900% |
506,185 (+14.46%) |
Filing History |